文献速递神经技术与安全PETMR

生成对抗网络增强的超低剂量[18F]-PI-2620 τ PET/MRI在衰老与神经退行性人群中的应用

Generative Adversarial Network-Enhanced Ultra-Low-Dose [18F]-PI-2620 τ PET/MRI in Aging and Neurodegenerative Populations.
PubMed 文献 · AJNR Am J Neuroradiol · 2023-08-17

本研究纳入44名健康衰老参与者和神经退行性疾病患者,同时采集[18F]-PI-2620 τ PET/MR数据,训练生成对抗网络从随机采样1/20(约原始计数5%)的超低剂量数据重建并增强τ图像,以MR图像为额外输入通道。区域分析和阅片研究显示增强图像噪声明显降低,健康但淀粉样蛋白阳性人群(τ摄取相对较低)的摄取低估偏差减小,示踪剂摄取模式的判读与全剂量图像一致。

要点

  • 增强超低剂量τ图像较超低剂量图像噪声明显降低
  • 健康但淀粉样蛋白阳性人群(τ摄取相对较低)中,增强图像减小了摄取低估偏差
  • 增强图像与全剂量图像的示踪剂摄取模式判读结果一致

核心结论

  • 深度学习增强的超低剂量τ PET图像的临床判读与全剂量成像一致,提示有可能降低剂量并实现更频繁的痴呆监测检查。

研究设计与样本

  • 研究纳入44名健康衰老参与者和神经退行性疾病患者,同时采集[18F]-PI-2620 τ PET/MR数据;生成对抗网络从随机采样1/20(约原始计数5%)的超低剂量数据重建并增强τ图像,MR图像作为额外输入通道;采用区域分析和阅片研究比较增强图像与全剂量图像。

关键影像表现/征象

  • 增强超低剂量τ图像较超低剂量图像噪声明显降低。
  • 区域标准摄取值比值显示两类图像总体均存在低估,尤其在摄取较高的区域。
  • 在健康但淀粉样蛋白阳性人群(τ摄取相对较低)中,增强超低剂量图像的低估偏差减小。

临床应用与阅片要点

  • 临床判读增强超低剂量τ PET图像时,示踪剂摄取模式判读结果与全剂量图像一致。
  • 在健康但淀粉样蛋白阳性人群中,增强图像可减小τ摄取低估偏差。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: With the utility of hybrid τ PET/MR imaging in the screening, diagnosis, and follow-up of individuals with neurodegenerative diseases, we investigated whether deep learning techniques can be used in enhancing ultra-low-dose [18F]-PI-2620 τ PET/MR images to produce diagnostic-quality images.

MATERIALS AND METHODS: Forty-four healthy aging participants and patients with neurodegenerative diseases were recruited for this study, and [18F]-PI-2620 τ PET/MR data were simultaneously acquired. A generative adversarial network was trained to enhance ultra-low-dose τ images, which were reconstructed from a random sampling of 1/20 (approximately 5% of original count level) of the original full-dose data. MR images were also used as additional input channels. Region-based analyses as well as a reader study were conducted to assess the image quality of the enhanced images compared with their full-dose counterparts.

RESULTS: The enhanced ultra-low-dose τ images showed apparent noise reduction compared with the ultra-low-dose images. The regional standard uptake value ratios showed that while, in general, there is an underestimation for both image types, especially in regions with higher uptake, when focusing on the healthy-but-amyloid-positive population (with relatively lower τ uptake), this bias was reduced in the enhanced ultra-low-dose images. The radiotracer uptake patterns in the enhanced images were read accurately compared with their full-dose counterparts.

CONCLUSIONS: The clinical readings of deep learning-enhanced ultra-low-dose τ PET images were consistent with those performed with full-dose imaging, suggesting the possibility of reducing the dose and enabling more frequent examinations for dementia monitoring.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Chen KT, Tesfay R, Koran MEI, et al. Generative Adversarial Network-Enhanced Ultra-Low-Dose [18F]-PI-2620 τ PET/MRI in Aging and Neurodegenerative Populations. AJNR Am J Neuroradiol. 2023. PMID: 37591771. doi:10.3174/ajnr.A7961

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。